Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.

GB, Cassano; MC, Jori

doi:10.1097/00004850-200201000-00004

Public

Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.

Shared by NobleBlocks on Jan 1, 2002 • 12:00 AM UTC

Authors:

Cassano GB

Jori MC

Abstract

The efficacy of amisulpride in depressive disorders has been demonstrated in dysthymia and in double depression. Limited data are available in major depression. A randomized, double-blind, parallel group, multicentre study was set up to compare the efficacy and tolerability of amisulpride (50 mg o.d...

Discussions